Propanc Biopharma, Inc.

Latest News

Jan 2, 2019

Propanc Biopharma Commences Drug Discovery Research Collaboration

University of Jaén to Co-fund 3 to 4 Year Program, Appoints Scientist to Lead Research Activities MELBOURNE, Australia--(BUSINESS WIRE)-- Propanc Biopharma, Inc. (OTCQB: PPCB)…

View All Press Releases

Dec 20, 2018

Propanc Biopharma’s Foundation Patent Granted in India

Dec 18, 2018

Propanc Biopharma Selects LaVoieHealthScience as Integrated Communications Partner

Oct 4, 2018

Propanc Biopharma Initiates European Validation of its Lead Patent
Latest Publication Antitumour efficacy of chymotrypsinogen and trypsinogen View All Publications
In vitro treatment of carcinoma cell lines with pancreatic (pro)enzymes suppresses the EMT programme and promotes cell differentiation
A formulation of pancreatic pro-enzymes provides potent anti-tumour efficacy: a pilot study focused on pancreatic and ovarian cancer